2,468 Shares in CVS Health Co. (NYSE:CVS) Acquired by Newbridge Financial Services Group Inc.

Newbridge Financial Services Group Inc. acquired a new stake in CVS Health Co. (NYSE:CVS) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 2,468 shares of the pharmacy operator’s stock, valued at approximately $111,000.

Other institutional investors have also modified their holdings of the company. MidAtlantic Capital Management Inc. purchased a new stake in CVS Health during the 3rd quarter worth about $25,000. Livelsberger Financial Advisory purchased a new stake in CVS Health during the third quarter worth approximately $31,000. Legacy Investment Solutions LLC acquired a new position in CVS Health in the third quarter valued at approximately $31,000. Reston Wealth Management LLC purchased a new position in CVS Health in the third quarter valued at approximately $32,000. Finally, Kathleen S. Wright Associates Inc. purchased a new stake in shares of CVS Health during the 3rd quarter worth approximately $33,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Performance

Shares of CVS stock opened at $54.24 on Tuesday. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75. The company has a market cap of $68.26 billion, a price-to-earnings ratio of 13.77, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. The stock has a 50 day simple moving average of $50.79 and a 200-day simple moving average of $55.98.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.90%. CVS Health’s payout ratio is currently 67.51%.

Wall Street Analyst Weigh In

CVS has been the topic of a number of recent analyst reports. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $60.00 to $66.00 in a research report on Monday, November 18th. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. TD Cowen upped their target price on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, November 25th. Royal Bank of Canada cut their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research report on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $68.12.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.